SP
Swartz Private Equity
Private EquityModerateSwartz Private Equity is an institutional private equity fund focused on small-cap issuers in the biotechnology and high technology space.
Atlanta, United StatesFounded 2007
6
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Swartz Private Equity.
Investment Thesis & Strategy
Swartz Private Equity invests in small-cap biotechnology and high-technology companies across various stages. They are an institutional private equity fund.
Investment Activity
Deals per year over the last 5 years
1
20141
20150
20160
20171
2018Portfolio Companies
Selected investments from their portfolio of 6 companies
V
Vaxart
Biotech · Growth, 2018
A
Aeglea BioTherapeutics
Biotech · Growth, 2015
P
Protagonist Therapeutics
Biotech · Growth, 2014
Frequently Asked Questions
Swartz Private Equity focuses on Series B, Series C+ stage investments.
Related Investors
Invesco
Atlanta, United States · 82 deals
BIP Capital
Atlanta, United States · 55 deals
Fulcrum Equity Partners
Atlanta, United States · 47 deals
First Light Ventures
Atlanta, United States · 10 deals
SunTrust Robinson Humphrey
Atlanta, United States · 8 deals
Roark Capital Group
Atlanta, United States · 8 deals